Raman’s review of life science in 2022

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, who reflects on the last 12 months in the life science industry. He covers his 5 key trends from the year including: The biotech capital market slowdown and its impact on the outsourcing space Sustainability as the hot topic within the sector, from events to company practices Businesses operating in an increasingly digital way and what that means for the tech companies supporting them The cooling of mergers and acquisitions activity in the life sciences industry A reduction of discussion around Covid-19 as it moves into the sector’s rear view Come back in 2023 for brand new episodes with great guests, including a special 100th episode celebration. Also, if you’re a previous guest, keep an eye out for an exclusive invitation in your inbox very soon… Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating! Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.